Shares in Recursion fell by 13.4% on 5 May, dropping from $5.49 at market open to $4.76 at close following the pipeline restructuring announcement. The terminated programmes include REC-2282, REC ...

Shares of Recursion Pharmaceuticals (RXRX 5.58%) were up more than 61% as of 11:30 a.m. on Wednesday. The clinical-stage biotech company announced that technology company Nvidia had made a $50 ...

Plus, collaborations do not need to be exclusively in the biopharma domain. Recursion's acumen with AI was sufficient for Nvidia to make a $50 million equity investment last year.It's faintly ...

SALT LAKE CITY, Nov. 20, 2024-- The business combination of two AI-powered drug discovery and development companies, Recursion and Exscientia has been completed, with Exscientia becoming a wholly ...